Abstract

Patients with chronic kidney disease (CKD) exhibit an elevated cardiovascular risk manifesting as coronary artery disease, heart failure, arrhythmias, and sudden cardiac death. Although the incidence and prevalence of cardiovascular events is already significantly higher in patients with early CKD stages (CKD stages 1–3) compared with the general population, patients with advanced CKD stages (CKD stages 4–5) exhibit a markedly elevated risk. Cardiovascular rather than end-stage kidney disease (CKD stage 5) is the leading cause of death in this high-risk population. CKD causes a systemic, chronic proinflammatory state contributing to vascular and myocardial remodeling processes resulting in atherosclerotic lesions, vascular calcification, and vascular senescence as well as myocardial fibrosis and calcification of cardiac valves. In this respect, CKD mimics an accelerated aging of the cardiovascular system. This overview article summarizes the current understanding and clinical consequences of cardiovascular disease in CKD.

Keywords

MedicineKidney diseaseCardiologyInternal medicineCoronary artery diseaseDiseasePopulationHeart failureSudden cardiac deathCause of death

MeSH Terms

AdultAgedAged80 and overCardiovascular DiseasesFemaleHumansMaleMiddle AgedRenal InsufficiencyChronicRisk Factors

Affiliated Institutions

Related Publications

Publication Info

Year
2021
Type
article
Volume
143
Issue
11
Pages
1157-1172
Citations
1565
Access
Closed

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1565
OpenAlex
16
Influential

Cite This

Joachim Jankowski, Jürgen Floege, Danilo Fliser et al. (2021). Cardiovascular Disease in Chronic Kidney Disease. Circulation , 143 (11) , 1157-1172. https://doi.org/10.1161/circulationaha.120.050686

Identifiers

DOI
10.1161/circulationaha.120.050686
PMID
33720773
PMCID
PMC7969169

Data Quality

Data completeness: 86%